Results 121 to 130 of about 47,030 (243)

Clinical Efficacy of Tofacitinib in Treating Granulomatous Reaction After Mesotherapy: A Case Series Analysis

Journal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Mesotherapy, a widely utilized minimally invasive cosmetic procedure, carries potential risks of adverse reactions due to non‐standardized protocols and overuse. Delayed granulomatous reactions represent a chronic complication, imposing significant physical and psychological burdens on patients.
Chang Shu, Tao Zhang, Jia‐Wei Liu, Chen‐yu Zhu, Rou‐yu Fang, Qiu‐ning Sun, Nian Li, Feng Li   +7 more
wiley   +1 more source

Thalidomide Neuropathy [PDF]

BMJ, 1963
openaire   +2 more sources

Rapid Recognition of Carfilzomib‐Induced Thrombotic Microangiopathy and Early Application of Eculizumab Successfully Rescued Two Relapsed Myeloma Patients

Chronic Diseases and Translational Medicine, Volume 12, Issue 1, Page 63-68, March 2026.
Zi Wang, Hua Zheng, Wei Wang, Xiaoxiao Shi, Yunpeng Wei, Chao Li, Junling Zhuang   +6 more
wiley   +1 more source

Sleep quality and sleepiness in adults with multiple myeloma. Is melatonin a potential treatment?

Physiological Reports, Volume 14, Issue 5, March 2026.
Abstract Sleep disturbances significantly impact quality of life in cancer patients, yet remain poorly characterized in multiple myeloma (MM). This observational study aimed to characterize sleep profiles in MM patients and evaluate the therapeutic potential of exogenous melatonin.
Mariana Fiori, Evellyn M. de Azevedo, Lais S. Rodrigues, Kamily S. Turt, Daniel Pacheco Bruschi, Marcelo M. S. Lima   +5 more
wiley   +1 more source

Thalidomide neuropathy [PDF]

Nature Medicine, 1996
openaire   +2 more sources

A Facile Protocol for C(sp2)–C(sp3) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands

ChemMedChem, Volume 21, Issue 4, 25 February 2026.
A robust C(sp2)–C(sp3) decarboxylative coupling strategy enables access to new CRBN ligands and degraders with improved physicochemical properties. This synthetic approach is expanding the chemical space beyond C(sp2)–N linkages, fine‐tuning proteolysis‐targeting chimera activities and unlocking previously inaccessible degrader chemotypes.
Anita Maksutova, Thomas M. Geiger, Lorenzo Cianni, Dominika E. Pieńkowska, Jan Gerhartz, Lina Read, Aleša Bricelj, Alexander Herrmann, Maurice Leon Nelles, Yuen Lam Dora Ng, Marcus D. Hartmann, Jan Krönke, Izidor Sosič, Radosław P. Nowak, Michael Gütschow, Christian Steinebach   +15 more
wiley   +1 more source

Role of thalidomide in angiodysplasia-related gastrointestinal bleeding: a systematic review. [PDF]

Front Gastroenterol (Lausanne)
Khan J, Yousaf Shah A, Khan AA, Shahid Raja R, Ahmed Z, Shahid Raja M, Eng S, Iqbal Q.   +7 more
europepmc   +1 more source

Case Report: Lupus miliaris disseminatus faciei successfully treated with thalidomide combined with photodynamic therapy: two cases and literature review. [PDF]

Front Immunol
Feng H, Sun Z, Li H, Han C, Zhang Z.
europepmc   +1 more source

Thalidomide as a rescue protocol for treatment of multiple myeloma in dogs: preliminary data from a multicentre retrospective study. [PDF]

Front Vet Sci
Ciccarelli S, Leo C, Perrone C, Franchini D, Bonazzi I, Finotello R.   +5 more
europepmc   +1 more source

Successful Remission of Refractory Oral Ulcers Treated with Low-Dose Thalidomide and Colchicine: A Case Report. [PDF]

Reports (MDPI)
Kan SY, Sung YK, Hsu CL, Chiu KC.
europepmc   +1 more source